- Home
- ADIL vs ABTS Comparison
ADIL vs ABTS Comparison
Compare ADIL & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADIL
- ABTS
- Stock Information
- Founded
- ADIL 2010
- ABTS 2010
- Country
- ADIL United States
- ABTS Hong Kong
- Employees
- ADIL N/A
- ABTS N/A
- Industry
- ADIL Biotechnology: Pharmaceutical Preparations
- ABTS Computer Software: Programming Data Processing
- Sector
- ADIL Health Care
- ABTS Technology
- Exchange
- ADIL Nasdaq
- ABTS Nasdaq
- Market Cap
- ADIL 7.7M
- ABTS 8.9M
- IPO Year
- ADIL 2018
- ABTS N/A
- Fundamental
- Price
- ADIL $0.31
- ABTS $6.11
- Analyst Decision
- ADIL Strong Buy
- ABTS
- Analyst Count
- ADIL 1
- ABTS 0
- Target Price
- ADIL $1.50
- ABTS N/A
- AVG Volume (30 Days)
- ADIL 434.1K
- ABTS 57.2K
- Earning Date
- ADIL 11-13-2025
- ABTS 08-13-2025
- Dividend Yield
- ADIL N/A
- ABTS N/A
- EPS Growth
- ADIL N/A
- ABTS N/A
- EPS
- ADIL N/A
- ABTS N/A
- Revenue
- ADIL N/A
- ABTS $7,037,156.00
- Revenue This Year
- ADIL N/A
- ABTS N/A
- Revenue Next Year
- ADIL N/A
- ABTS N/A
- P/E Ratio
- ADIL N/A
- ABTS N/A
- Revenue Growth
- ADIL N/A
- ABTS 31.69
- 52 Week Low
- ADIL $0.22
- ABTS $1.35
- 52 Week High
- ADIL $1.30
- ABTS $14.10
- Technical
- Relative Strength Index (RSI)
- ADIL 38.13
- ABTS 44.85
- Support Level
- ADIL $0.31
- ABTS $5.80
- Resistance Level
- ADIL $0.33
- ABTS $6.61
- Average True Range (ATR)
- ADIL 0.02
- ABTS 0.52
- MACD
- ADIL -0.00
- ABTS -0.06
- Stochastic Oscillator
- ADIL 2.49
- ABTS 28.18
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.